Price Performance
- Day's Low
- ₹1,693.30
- Day's High
- ₹1,708
₹ 1,698.55
- 52-w low
- ₹1,475.05
- 52-w high
- ₹2,220.95
1,698.55
- Day's open
₹1,708 - Previous close
₹1,702.50 - VWAP
₹1,699.52 - Lower price band
₹1,358.85 - Upper price band
₹2,038.25
Today's Market Action
The last traded share price of Gland Pharma Ltd was 1,698.55 down by -0.23% on the NSE. Its last traded stock price on BSE was 1,698.85 down by -0.10%. The total volume of shares on NSE and BSE combined was 82,520 shares. Its total combined turnover was Rs 14.02 crores.
Medium and Long Term Market Action
Gland Pharma Ltd hit a 52-week high of 2,220.95 on 06-08-2024 and a 52-week low of 1,475.05 on 26-10-2023.
The stock price of Gland Pharma Ltd is down by -10% over the last one month. It is up by 3.7% over the last one year. Don't forget to check the full stock price history in the table below.
Fundamentals
-
Market Cap (Cr): 27984
-
Book Value (₹):
-
Stock P/E:
-
Revenue (Cr):
-
Total Debt (Cr):
-
Face Value (₹):
-
Roce (%):
-
ROE (%):
-
Earnings (Cr):
-
Promoter’s Holdings (%):
-
EPS (₹):
-
Debt to Equity:
-
Dividend Yield (%):
-
Cash (Cr):
Mutual fund holdings and trends
FUND NAME | Quantity | Monthly Change (Qty) |
---|
Similar Stocks
Company | Price | Market Cap (Cr) | P/E |
---|
About
Data not available.
FAQ's
What is Share Price of Gland Pharma Ltd?
What is the Market Cap of Gland Pharma Ltd?
What is PE Ratio of Gland Pharma Ltd?
What is PB Ratio of Gland Pharma Ltd?
What is the CAGR of Gland Pharma Ltd?
How to Buy Gland Pharma Ltd Share?
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
Consolidated Financial Performace In Graph(Net Profit)
Standalone Financial Performace In Graph(Net Profit)
(*All values are in Rs. Cr)
Consolidated Financial Performace In Graph(Net Profit)
Standalone Financial Performace In Graph(Net Profit)
(*All values are in Rs. Cr)
Consolidated Financial Performace In Graph(Cash Flow)
Standalone Financial Performace In Graph(Cash Flow)
Pros
Above Average Sustainable RoE
Great Cash Conversion of Profits
High Pricing Power
Zero Debt
Above Average Growth Rate
Cons
Momentum Strength
Poor Working Capital Cycle
Valuation Analysis
Margin of safety
(13/10/2024)
(13/10/2024)
105
83.33%
83.33% People are bullish about Gland Pharma Ltd
16.67%
16.67 % People are bearish about Gland Pharma Ltd